Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 3330

Journal of Biotechnology & Biomaterials received 3330 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Putative t-RNA dihydrouridine synthase from Saccharomyces cerevisae (MTCC-181) as a biomarker for malignant cells

3rd World Congress on Biotechnology

Parul Aggarwal Pruthi, Naresh Kumar, Alok Patel, Vikas Pruthi and R.P. Singh

Posters: Agrotechnol

DOI: 10.4172/2155-952X.S1.020

Abstract
Using comparative genomics and computational methods, we have identified the structural & functional aspect of a putative t-RNA dihydrouridine synthase encoding gene of Saccharomyces cerevisae (MTCC-181) by homology modeling approach.Dihydrouridine synthases (DUSs, EC 1.3.1.91) are flavin-dependent enzymes that catalyze site-specific reduction of uracils in tRNAs. A putative protein of 668 amino acids was analyzed. It contains 12-FMN-binding conserve domain on the active site, characteristics of DUS_like_FMN super-family (cd02801, E-value=3.21e-63) which catalyzes the reduction of the 5, 6-double bond of a uridine residue on tRNA. Four catalytic residues 386 (Cys), 428 (Arg), 457 (His) and 459 (Arg) were found on the DUS-like conserved domain (294-557), among which an active site cysteine is important for catalysis, likely through the protonation of uracil during tRNA reduction. The protein have multi-domains with high similarity to COG0042 (CDD, 284-597); a tRNA-dihydrouridine synthase (E-value=1.07e-62) and TIM barrel superfamily (cl09108, 296-550, E-value=3.83-20) which share a structurally conserved phosphate binding motif and in general have an eight β/α closed barrel structure. The structure of an FMN-binding α/β-barrel also has significant similarity to dihydroorotate dehydrogenases and dihydropyrimidine dehydrogenases. Three dimensional (3D) structure was constructed by modeller 9v7 modeling software by using the 1VHN (4.4e-15 & similarity =76%) as a template. Binding of substrate (uracil-t-RNA) and acceptor molecules (NADPH and FMN) were confirmed by Autodock 4.2.Dihydrouridine modification of tRNA is widely observed in prokaryotes and eukaryotes. Most dihydrouridines occurs in specific positions in the D-loop of t-RNAs. The role of dihydrouridine synthase in oxidation of uracil bound t-RNA to tRNA-dihydrouridine by simultaneous reduction of acceptor molecule like NADPH and FMN were confirmed by enzymatic assay. Increase in tRNA dihydrouridine synthase activity was detected in human lung carcinoma cells (ATCC Number-TCP-1016) as compare to normal tissue. It is likely that different family members have different substrate specificities, which may overlap. Abundance of dihydrouridine is linked to pulmonary carcinoma. It was observed that hypermodified t-RNA-dihydrouridine has a specific functional role for growth of cancer cells, through the complex of tRNA-DUS protein combined with aminoacyl tRNA synthetase. This complex is a strong therapeutic target for new anticancer drugs.
Biography
Parul Aggarwal Pruthi has done her Ph.D in 1998 from IMTECH Chandigarh and was Post-Doc fellow in Indiana University Purdue University, Indiana Polis (IUPUI). Presently she is working as Scientist (DBT Biocare Program), Department of Biotechnology, IIT Roorkee. Dr. Parul has several publications in reputed journal and many international and national conferences.
Top